Ccr10-flox 基因敲除小鼠

1. Hohmann, Miriam S, Habiel, David M, Espindola, Milena S, Murray, Lynne A, Hogaboam, Cory M. 2021. Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF. In JCI insight, 6, . doi:10.1172/jci.insight.141061. https://pubmed.ncbi.nlm.nih.gov/33945505/

2. Zhou, Zengding, Yang, Huizhong, Wang, Xiqiao, Yi, Lei. . Blocking CCR10 Expression Activates m6A Methylation and Alleviates Vascular Endothelial Cell Injury. In Discovery medicine, 35, 36-44. doi:10.24976/Discov.Med.202335174.5. https://pubmed.ncbi.nlm.nih.gov/37024440/

3. Li, Baijun, Wei, Caizhou, Zhong, Yonglong, Huang, Jianwei, Li, Rizhu. 2022. The CCL27-CCR10 axis contributes to promoting proliferation, migration, and invasion of lung squamous cell carcinoma. In Histology and histopathology, 38, 349-357. doi:10.14670/HH-18-525. https://pubmed.ncbi.nlm.nih.gov/36169116/

4. Lin, Hao-Yu, Sun, Shu-Ming, Lu, Xiao-Feng, Liang, Wei-Quan, Peng, Chun-Yan. 2017. CCR10 activation stimulates the invasion and migration of breast cancer cells through the ERK1/2/MMP-7 signaling pathway. In International immunopharmacology, 51, 124-130. doi:10.1016/j.intimp.2017.07.018. https://pubmed.ncbi.nlm.nih.gov/28830025/